Trial intelligence / Profile preview

Neutrogena Light Therapy Mask vs Benzoyl Peroxide and Adapalene for Acne

NCT03650881Withdrawn

Sponsor
NYU Langone Health
Start
Aug 2018
Primary completion
Feb 2020
01

Overview

Randomised, single-blind trial in acne vulgaris, sponsored by NYU Langone Health. Primary endpoint: Investigator Global Assessment at 12 weeks. Planned start Aug 2018; status: withdrawn.

02

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT03650881.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03650881.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call